A simple method to estimate the episode and programme sensitivity of breast cancer screening programmes
- PMID: 20956723
- DOI: 10.1258/jms.2010.009060
A simple method to estimate the episode and programme sensitivity of breast cancer screening programmes
Abstract
Background: The estimation of breast cancer screening sensitivity is a major aim in the quality assessment of screening programmes. The proportional incidence method for the estimation of the sensitivity of breast cancer screening programmes is rarely used to estimate the underlying incidence rates.
Methods: We present a method to estimate episode and programme sensitivity of screening programmes, based solely on cancers detected within screening cycles (excluding breast cancer cases at prevalent screening round) and on the number of incident cases in the total target population (steady state). The assumptions, strengths and limitations of the method are discussed. An example of calculation of episode and programme sensitivities is given, on the basis of the data from the IMPACT study, a large observational study of breast cancer screening programmes in Italy.
Results: The programme sensitivity from the fifth year of screening onwards ranged between 41% and 48% of the total number of cases in the target population. At steady state episode sensitivity was 0.70, with a trend across age groups, with lowest values in women aged 50-54 years (0.52) and highest in those 65-69 (0.77).
Conclusions: The method is a very serviceable tool for estimating sensitivity in service screening programmes, and the results are comparable with those of other methods of estimation.
Similar articles
-
Interval cancer incidence and episode sensitivity in the Norrbotten Mammography Screening Programme, Sweden.J Med Screen. 2009;16(1):39-45. doi: 10.1258/jms.2009.008098. J Med Screen. 2009. PMID: 19349530
-
Effect of participation on the cumulative risk of false-positive recall in a breast cancer screening programme.Public Health. 2009 Sep;123(9):635-7. doi: 10.1016/j.puhe.2009.07.007. Epub 2009 Sep 4. Public Health. 2009. PMID: 19733372 No abstract available.
-
Estimates of overdiagnosis of invasive breast cancer associated with screening mammography.Cancer Causes Control. 2010 Feb;21(2):275-82. doi: 10.1007/s10552-009-9459-z. Epub 2009 Nov 6. Cancer Causes Control. 2010. PMID: 19894130
-
[Breast self-examination also valuable in women participating in a screening programme].Ned Tijdschr Geneeskd. 2008 Oct 25;152(43):2341-5. Ned Tijdschr Geneeskd. 2008. PMID: 19024066 Dutch.
-
Effectiveness of skin cancer screening programmes.Br J Dermatol. 2012 Aug;167 Suppl 2:94-8. doi: 10.1111/j.1365-2133.2012.11091.x. Br J Dermatol. 2012. PMID: 22881593 Review.
Cited by
-
Co-expression of Oct-4 and Nestin in human breast cancers.Mol Biol Rep. 2012 May;39(5):5875-81. doi: 10.1007/s11033-011-1398-6. Epub 2011 Dec 30. Mol Biol Rep. 2012. PMID: 22207173
-
A simple way to measure the burden of interval cancers in breast cancer screening.BMC Cancer. 2014 Oct 24;14:782. doi: 10.1186/1471-2407-14-782. BMC Cancer. 2014. PMID: 25344115 Free PMC article.
-
Estimation of age of onset and progression of breast cancer by absolute risk dependent on polygenic risk score and other risk factors.Cancer. 2024 May 1;130(9):1590-1599. doi: 10.1002/cncr.35183. Epub 2024 Jan 4. Cancer. 2024. PMID: 38174903 Free PMC article.
-
Estimating Cancer Screening Sensitivity and Specificity Using Healthcare Utilization Data: Defining the Accuracy Assessment Interval.Cancer Epidemiol Biomarkers Prev. 2022 Aug 2;31(8):1517-1520. doi: 10.1158/1055-9965.EPI-22-0232. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 35916602 Free PMC article.
-
Estimating the Burden of False Positives and Implementation Costs From Adding Multiple Single Cancer Tests or a Single Multi-Cancer Test to Standard-Of-Care Screening.Cancer Med. 2025 Mar;14(6):e70776. doi: 10.1002/cam4.70776. Cancer Med. 2025. PMID: 40095751 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical